Try our beta test site
1 study found for:    NCT01691898
Show Display Options
Rank Status Study
1 Active, not recruiting A Study of Pinatuzumab Vedotin (DCDT2980S) Combined With Rituximab or Polatuzumab Vedotin (DCDS4501A) Combined With Rituximab or Obinutuzumab in Participants With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma
Condition: Lymphoma, Follicular, Diffuse Large B-Cell Lymphoma
Interventions: Drug: Obinutuzumab;   Drug: Pinatuzumab Vedotin;   Drug: Polatuzumab Vedotin;   Drug: Rituximab

Study has passed its completion date and status has not been verified in more than two years.